Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nancy Ann Rigotti, M.D.

Co-Author

This page shows the publications co-authored by Nancy Rigotti and Sarah Wakeman.
Connection Strength

2.241
  1. Impact of Fentanyl Use on Buprenorphine Treatment Retention and Opioid Abstinence. J Addict Med. 2019 Jul/Aug; 13(4):253-257.
    View in: PubMed
    Score: 0.845
  2. Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction Severity. J Gen Intern Med. 2017 Aug; 32(8):909-916.
    View in: PubMed
    Score: 0.729
  3. Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. Drug Alcohol Depend. 2021 01 01; 218:108438.
    View in: PubMed
    Score: 0.233
  4. The effectiveness of post-discharge navigation added to an inpatient addiction consultation for patients with substance use disorder; a randomized controlled trial. Subst Abus. 2020 Sep 03; 1-8.
    View in: PubMed
    Score: 0.229
  5. Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization. J Gen Intern Med. 2019 06; 34(6):871-877.
    View in: PubMed
    Score: 0.204
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.